|
|
|
|
LEADER |
00000cam a2200000 4500 |
001 |
EBOOKCENTRAL_ocn870228520 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr |n||||||||| |
008 |
140208s2014 xx o 000 0 eng d |
040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d OCLCO
|d OCLCQ
|d DEBSZ
|d OCLCQ
|d LOA
|d OCLCO
|d K6U
|d OCLCF
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCL
|
020 |
|
|
|a 9781317733768
|
020 |
|
|
|a 1317733762
|
029 |
1 |
|
|a AU@
|b 000052912108
|
029 |
1 |
|
|a DEBSZ
|b 431621748
|
029 |
1 |
|
|a DEBSZ
|b 449414132
|
029 |
1 |
|
|a GBVCP
|b 778325733
|
035 |
|
|
|a (OCoLC)870228520
|
050 |
|
4 |
|a HD9999.B442 C663 2014
|
082 |
0 |
4 |
|a 338.476606
|
049 |
|
|
|a UAMI
|
100 |
1 |
|
|a Coombs, Joseph E.
|
245 |
1 |
0 |
|a International Strategy and Market Performance in New Biotechnology Firms.
|
260 |
|
|
|a Hoboken :
|b Taylor and Francis,
|c 2014.
|
300 |
|
|
|a 1 online resource (111 pages)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Transnational Business and Corporate Culture
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Cover; Transnational Business and Corporate Culture; Title Page; Copyright Page; Dedication; Table of Contents; Preface; Acknowledgments; List of Tables and Figures; Chapter 1 Introduction; Chapter 2 Theory and Hypotheses; Biotechnology Research; Literature Review: International Entrepreneurship; Literature Review: Organizational Change; Hypotheses; Chapter 3 Methodology; Research Design; Sample Selection; Measures of Constructs, Model I; Measures of Constructs, Model II; Measures of Constructs, Model III; Chapter 4 Analysis and Results; Data Analysis; Descriptive Statistics.
|
505 |
8 |
|
|a Direction of Change in International StrategyForeign Revenue as a Percentage of Total Revenue; Firm Market Value; Chapter 5 Discussion and Conclusions; Discussion of Results; Limitations of the Study; Future Research; Appendix A Firms Included in Study; Appendix B Sample Coding Sheet; References; Index.
|
520 |
|
|
|a The issues addressed in this study are: What internal factors support changes in the international operations of new firms? and What effect do these changes have on the firm's structure, control system, and market performance. To answer these questions, this work examines the internal resources and market performance of a set of publicly traded biotechnology firms. Findings support the view that new firms can enter international markets through a variety of strategies, including international joint ventures and subsidiaries. Changes in international operations also are found to enhance firm.
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
650 |
|
0 |
|a Biotechnology industries.
|
650 |
|
0 |
|a New business enterprises.
|
650 |
|
0 |
|a International business enterprises.
|
650 |
|
0 |
|a International trade.
|
650 |
|
6 |
|a Bio-industries.
|
650 |
|
6 |
|a Nouvelles entreprises.
|
650 |
|
6 |
|a Entreprises multinationales.
|
650 |
|
6 |
|a Commerce international.
|
650 |
|
7 |
|a Biotechnology industries
|2 fast
|
650 |
|
7 |
|a International business enterprises
|2 fast
|
650 |
|
7 |
|a International trade
|2 fast
|
650 |
|
7 |
|a New business enterprises
|2 fast
|
758 |
|
|
|i has work:
|a International strategy and market performance in new biotechnology firms (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCGb3yhF3cgjkJ7JJRhVV4q
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
776 |
0 |
8 |
|i Print version:
|a Coombs, Joseph E.
|t International Strategy and Market Performance in New Biotechnology Firms.
|d Hoboken : Taylor and Francis, ©2014
|z 9780815335016
|
830 |
|
0 |
|a Transnational business and corporate culture.
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=1619373
|z Texto completo
|
936 |
|
|
|a BATCHLOAD
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL1619373
|
994 |
|
|
|a 92
|b IZTAP
|